These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11501783)

  • 1. Antimetastasis gene expression and numerical chromosomal abnormalities of chromosomes 1 & 17 in serous tumours of the ovary.
    Kaya H; Evans MF; Ekicioglu G; Tuzlali S; Küllü S; Foster C
    Eur J Gynaecol Oncol; 2001; 22(3):240-2. PubMed ID: 11501783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours.
    Evans MF; McDicken IW; Herrington CS
    J Pathol; 1999 Sep; 189(1):53-9. PubMed ID: 10451488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Numerical aberrations of chromosome 17 in interphase cell nuclei of breast carcinoma cells: lack of correlation with abnormal expression of p53, neu and nm23 protein.
    Sauer T; Beraki K; Jebsen PW; Ormerod E; Naess O
    APMIS; 1998 Oct; 106(10):921-7. PubMed ID: 9833692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of nm23 expression and chromosome 17 numerical aberrations in primary gastric cancer.
    Terada R; Yasutake T; Nakamura S; Hisamatsu T; Sawai T; Yamaguchi H; Nakagoe T; Ayabe H; Tagawa Y
    Med Oncol; 2002; 19(4):239-48. PubMed ID: 12512918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis.
    Viel A; Dall'Agnese L; Canzonieri V; Sopracordevole F; Capozzi E; Carbone A; Visentin MC; Boiocchi M
    Cancer Res; 1995 Jun; 55(12):2645-50. PubMed ID: 7780979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer.
    Baekelandt M; Holm R; Tropé CG; Nesland JM; Kristensen GB
    Ann Oncol; 1999 Nov; 10(11):1335-41. PubMed ID: 10631462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
    Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
    Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of NM23 and tenascin in invasive ductal carcinomas of the breast.
    Kaya H; Hücümenoğlu S; Bozkurt SU; Ekicioğlu G; Kotiloğlu E
    Eur J Gynaecol Oncol; 2002; 23(3):261-3. PubMed ID: 12094967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. nm23-H1 gene expression in ovarian tumors--a potential tumor marker.
    Kapitanovic S; Spaventi R; Vujsic S; Petrovic Z; Kurjak A; Pavelic ZP; Gluckman JL; Stambrook PJ; Pavelic K
    Anticancer Res; 1995; 15(2):587-90. PubMed ID: 7763042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. nm23 expression in advanced and borderline ovarian carcinoma.
    Schneider J; Romero H; Ruiz R; Centeno MM; Rodriguez-Escudero FJ
    Anticancer Res; 1996; 16(3A):1197-202. PubMed ID: 8702236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic imbalance is not restricted to numerically abnormal chromosomes in epithelial ovarian tumours.
    Evans MF; Herrington CS
    J Pathol; 2001 Nov; 195(4):443-50. PubMed ID: 11745676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression P53 protein and chromosome aberrations in benign tumors and ovarian carcinoma].
    Kamiński K; Putowski L; Oleszczuk J
    Ginekol Pol; 2003 Sep; 74(9):741-5. PubMed ID: 14674118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and biological determinants in undifferentiated and poorly differentiated ovarian carcinomas.
    Canzonieri V; Viel A; Visentin MC; Perin T; Sopracordevole F; Dall'Agnese L; Scara-Belli C; Boiocchi M; Carbone A
    Pathologica; 1995 Oct; 87(5):492-7. PubMed ID: 8868173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. nm23 expression in tissue sections and tumor effusion cells of ovarian neoplasms.
    Harłozińska A; Bar JK; Gerber J
    Int J Cancer; 1996 Oct; 69(5):415-9. PubMed ID: 8900377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NM23 in Ovarian Cancer. Correlation with clinicopathological and biochemical parameters.
    Ferrandina G; Scambia G; Marone M; Benedetti Panici P; Giannitelli C; Pernisco S; Coronetta F; Mancuso S
    Ann N Y Acad Sci; 1996 Apr; 784():509-12. PubMed ID: 8651607
    [No Abstract]   [Full Text] [Related]  

  • 16. Mutation of the nm23 gene, loss of heterozygosity at the nm23 locus and K-ras mutation in ovarian carcinoma: correlation with tumour progression and nm23 gene expression.
    Mandai M; Konishi I; Komatsu T; Mori T; Arao S; Nomura H; Kanda Y; Hiai H; Fukumoto M
    Br J Cancer; 1995 Sep; 72(3):691-5. PubMed ID: 7669582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma.
    Tannapfel A; Köckerling F; Katalinic A; Wittekind C
    Dis Colon Rectum; 1995 Jun; 38(6):651-4. PubMed ID: 7774480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. nm23-H1 expression defines a high-risk subpopulation of patients with early-stage epithelial ovarian carcinoma.
    Schneider J; Pollán M; Jiménez E; Marenbach K; Martínez N; Volm M; Marx D; Meden H
    Br J Cancer; 2000 May; 82(10):1662-70. PubMed ID: 10817501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nm-23, c-erbB-2, and progesterone receptor expression in invasive breast cancer: correlation with clinicopathologic parameters.
    Nakopoulou LL; Tsitsimelis D; Lazaris AC; Tzonou A; Gakiopoulou H; Dicoglou CC; Davaris PS
    Cancer Detect Prev; 1999; 23(4):297-308. PubMed ID: 10403901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma.
    Zafon C; Obiols G; Castellví J; Tallada N; Galofré P; Gemar E; Mesa J; Simó R
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3975-80. PubMed ID: 11502841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.